Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Dare Bioscience Inc (DARE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Dare Bioscience's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.3099 +0.0148    +5.02%
09:35:19 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 79,801
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.2833 - 0.3099
Dare Bioscience 0.3099 +0.0148 +5.02%

DARE Balance Sheet

 
Featured here, the Balance Sheet for Dare Bioscience Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Current Assets 17.54 22.44 22.24 29.51
Cash and Short Term Investments 10.48 13.89 13.33 19.83
Cash - - - -
Cash & Equivalents 10.48 13.89 13.33 19.83
Short Term Investments - - - -
Total Receivables, Net 0.949 1.13 0.572 2.4
Accounts Receivables - Trade, Net - - - -
Total Inventory - - - -
Prepaid Expenses 6.12 6.58 8.07 7.08
Other Current Assets, Total - 0.831 0.272 0.201
Total Assets 21.28 25.05 23.21 30.37
Property/Plant/Equipment, Total - Net 1.98 0.241 0.322 0.423
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term 0.949 1.13 0.572 2.4
Other Long Term Assets, Total 1.76 2.38 0.645 0.431
Other Assets, Total -0.949 -0.298 -0.3 -2.2
Total Current Liabilities 20.48 26.34 24.7 24.34
Accounts Payable 3.39 4.99 6.54 2.7
Payable/Accrued - - - -
Accrued Expenses 2.89 5.29 4.19 5.48
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 0.469 0.195 0.272 0.336
Other Current liabilities, Total 13.74 15.87 13.69 15.83
Total Liabilities 26.33 27.34 25.93 25.4
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 5.85 1 1.23 1.06
Total Equity -5.05 -2.29 -2.72 4.97
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.01 0.01 0.009 0.009
Additional Paid-In Capital 166.54 164.3 155.56 154.45
Retained Earnings (Accumulated Deficit) -171.24 -166.18 -157.88 -149.12
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -0.361 -0.419 -0.404 -0.373
Total Liabilities & Shareholders' Equity 21.28 25.05 23.21 30.37
Total Common Shares Outstanding 99.97 98.29 86.63 86.18
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

DARE Comments

Write your thoughts about Dare Bioscience Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Vlad Stikhanovskii
Vlad Stikhanovskii Dec 09, 2021 4:43PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
back to 1.75...
Reply
3 2
Report
Ma Wa
Ma Wa Dec 09, 2021 4:43PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
1.75 was a good price :D
Reply
0 0
Report
Jacky Lee
Jacky Lee Dec 06, 2021 11:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No brainer buy!!
Reply
5 0
Report
Maor Gavriel
Maor Gavriel Oct 27, 2021 2:54AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
When will be the discussion whether ther get the FDA approval?
Reply
2 0
Report
Joshua Taylor
Joshua Taylor Aug 24, 2021 1:18PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
To $30! 🚀🚀🚀Just waiting on the FDA, theyre slower than molassis unless their dealing with big money and political pressure. With enough bribes, they’ll approve the clinical use of snake oil.
Reply
5 0
Report
Jacky Lee
Jacky Lee Aug 10, 2021 5:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The first drug is so close to fda approval and commecialization and revenue generation from zero base. Yet the share price has been stagnant for longest time. Whats wrong?
Reply
4 0
Report
Ahmed Almuqayad
Ahmed Almuqayad Aug 10, 2021 5:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think it will explode maybe today. it's very undervalued stock. it should be 10 usd.
Reply
2 0
Report
Joshua Taylor
Joshua Taylor Aug 10, 2021 5:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bill Gates recently granted money to Dare Bioscience. 🚀
Reply
1 0
Report
Feed Seow
Feed Seow Jul 09, 2021 10:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Abbott will pay good money for Dare
Reply
3 0
Report
Rambi Zambi
Rambi Zambi Jul 09, 2021 4:34AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This us one of WSB reditt stock
Reply
2 0
Report
Rambi Zambi
Rambi Zambi Jul 09, 2021 4:34AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Abbott will end in buying this co
Reply
0 0
Report
Ashkan Rahimi
Ashkan Rahimi Jul 08, 2021 10:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
xela is next wallbets stock
Reply
1 2
Report
NY Brokers Stock Exchange
NY Brokers Stock Exchange Jul 08, 2021 8:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i have no experience in crude oil sorry only in equities is good to buy now Dare but if you want more advises you can ask me
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email